|
1
|
Mamoulakis C, Tsarouhas K, Fragkiadoulaki
I, Heretis I, Wilks MF, Spandidos DA, Tsitsimpikou C and Tsatsakis
A: Contrast-induced nephropathy: Basic concepts, pathophysiological
implications and prevention strategies. Pharmacol Ther. 180:99–112.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Katzberg RW and Haller C: Contrast-induced
nephrotoxicity: Clinical landscape. Kidney Int Suppl.
(S3-S7)2006.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Andreucci M, Faga T, Pisani A, Sabbatini
M, Russo D and Michael A: Prevention of contrast-induced
nephropathy through a knowledge of its pathogenesis and risk
factors. ScientificWorldJournal. 2014(823169)2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Morcos SK and Thomsen HS: European Society
of Urogenital Radiology: European society of urogenital radiology
guidelines on administering contrast media. Abdom Imaging.
28:187–190. 2003.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Andreucci M, Solomon R and Tasanarong A:
Side effects of radiographic contrast media: Pathogenesis, risk
factors, and prevention. Biomed Res Int.
2014(741018)2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Moos SI, van Vemde DN, Stoker J and Bipat
S: Contrast induced nephropathy in patients undergoing intravenous
(IV) contrast enhanced computed tomography (CECT) and the
relationship with risk factors: A meta-analysis. Eur J Radiol.
82(e387-e399)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
McCullough PA, Adam A, Becker CR, Davidson
C, Lameire N, Stacul F and Tumlin J: CIN Consensus Working Panel.
Epidemiology and prognostic implications of contrast-induced
nephropathy. Am J Cardiol. 98(5K-13K)2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Guillon B, Ecarnot F, Marcucci C, Ducloux
D, Chatot M, Badoz M, Bonnet B, Chopard R, Frey P, Meneveau N and
Schiele F: Incidence, predictors, and impact on six-month mortality
of three different definitions of contrast-induced acute kidney
injury after coronary angiography. Am J Cardiol. 121:818–824. 2018.
View Article : Google Scholar
|
|
9
|
Gilchrist IC, Awuor SO, Davies RE and
Ukaigwe AC: Controversies in complex percutaneous coronary
intervention: Radial versus femoral. Expert Rev Cardiovasc Ther.
15:695–704. 2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
General Assembly of the World Medical
Association. World medical association declaration of Helsinki:
Ethical principles for medical research involving human subjects. J
Am Coll Dent. 81:14–18. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Rear R, Bell RM and Hausenloy DJ:
Contrast-induced nephropathy following angiography and cardiac
interventions. Heart. 102:638–648. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Levey AS, Bosch JP, Lewis JB, Greene T,
Rogers N and Roth D: A more accurate method to estimate glomerular
filtration rate from serum creatinine: A new prediction equation.
Modification of diet in renal disease study group. Ann Intern Med.
130:461–470. 1999.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Muñoz de Bustillo Llorente E and de Miguel
Balsa E: Radiological iodinated contrast-induced nephropathy. Rev
Clin Esp. 219:403–410. 2019.(In English, Spanish).
|
|
14
|
Azzalini L, Spagnoli V and Ly HQ:
Contrast-induced nephropathy: From pathophysiology to preventive
strategies. Can J Cardiol. 32:247–255. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Gosling R and Iqbal J: Predicting contrast
induced nephropathy in patients undergoing percutaneous coronary
intervention. J Thorac Dis. 11:2672–2674. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fähling M, Seeliger E, Patzak A and
Persson PB: Understanding and preventing contrast-induced acute
kidney injury. Nat Rev Nephrol. 13:169–180. 2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Fibrinogen Studies C, Danesh J, Lewington
S, Thompson SG, Lowe GD, Collins R, Kostis JB, Wilson AC, Folsom
AR, Wu K, et al: Plasma fibrinogen level and the risk of major
cardiovascular diseases and nonvascular mortality: An individual
participant meta-analysis. JAMA. 294:1799–1809. 2005.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Lowe GD, Fowkes FG, Dawes J, Donnan PT,
Lennie SE and Housley E: Blood viscosity, fibrinogen, and
activation of coagulation and leukocytes in peripheral arterial
disease and the normal population in the Edinburgh artery study.
Circulation. 87:1915–1920. 1993.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Druid H, Nilsson I, Rammer L and Skude G:
Effect of anticoagulation on renal function and protein excretion
in experimental acute ischemic renal failure. Ren Fail. 21:647–657.
1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Sörensen-Zender I, Rong S, Susnik N, Lange
J, Gueler F, Degen JL, Melk A, Haller H and Schmitt R: Role of
fibrinogen in acute ischemic kidney injury. Am J Physiol Renal
Physiol. 305(F777-F785)2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Huang MJ, Wei RB, Su TY, Wang Y, Li QP,
Yang X, Lv XM and Chen XM: Impact of acute kidney injury on
coagulation in adult minimal change nephropathy. Medicine
(Baltimore). 95(e5366)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Krishnamoorthy A, Ajay AK, Hoffmann D, Kim
TM, Ramirez V, Campanholle G, Bobadilla NA, Waikar SS and Vaidya
VS: Fibrinogen β-derived Bβ(15-42) peptide protects against kidney
ischemia/reperfusion injury. Blood. 118:1934–1942. 2011.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Mayosi BM, Keavney BD, Watkins HC, Vickers
MA and Green FR: Quantitative genetic study of plasma fibrinogen
level and the-455 G/A polymorphism of the beta-fibrinogen gene
using novel family-based association methods. Circulation.
102(104)2000.
|
|
24
|
Carty CL, Cushman M, Jones D, Lange LA,
Hindorff LA, Rice K, Jenny NS, Durda JP, Walston J, Carlson CS, et
al: Associations between common fibrinogen gene polymorphisms and
cardiovascular disease in older adults. The cardiovascular health
study. Thromb Haemost. 99:388–395. 2008.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Thompson SG, Fechtrup C, Squire E, Heyse
U, Breithardt G, van de Loo JC and Kienast J: Antithrombin III and
fibrinogen as predictors of cardiac events in patients with angina
pectoris. Arterioscl Throm Vas. 16:357–362. 1996.PubMed/NCBI View Article : Google Scholar
|
|
26
|
De Luca G, Verdoia M, Cassetti E, Schaffer
A, Cavallino C and Bolzani V: Novara Atherosclerosis Study Group
(NAS). High fibrinogen level is an independent predictor of
presence and extent of coronary artery disease among Italian
population. J Thromb Thrombolysis. 31:458–463. 2011.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Docherty NG and Godson C: Fibrinogen as a
damage-associated mitogenic signal for the renal fibroblast. Kidney
Int. 80:1014–1016. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Laurens N, Koolwijk P and De Maat MP:
Fibrin structure and wound healing. J Thromb Haemost. 4:932–939.
2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kerr R, Stirling D and Ludlam CA:
Interleukin 6 and haemostasis. Brit J Haematol. 115:3–12.
2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Szaba FM and Smiley ST: Roles for thrombin
and fibrin(ogen) in cytokine/chemokine production and macrophage
adhesion in vivo. Blood. 99:1053–1059. 2002.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Hossain MA, Costanzo E, Cosentino J, Patel
C, Qaisar H, Singh V, Khan T, Cheng JS, Asif A and Vachharajani TJ:
Contrast-induced nephropathy: Pathophysiology, risk factors, and
prevention. Saudi J Kidney Dis Transpl. 29:1–9. 2018.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Meng R, Li ZY, Ji X, Ding Y, Meng S and
Wang X: Antithrombin III associated with fibrinogen predicts the
risk of cerebral ischemic stroke. Clin Neurol Neurosur.
113:380–386. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ersoy B, Nehir H, Altinoz S, Yilmaz O,
Dundar PE and Aydogan A: Prognostic value of initial antithrombin
levels in neonatal sepsis. Indian Pediatr. 44:581–584.
2007.PubMed/NCBI
|
|
34
|
Samra N, AlGhwass M, Elgawhary S, Hassan
M, Bekhit O, Mohamed W and Eid M: Serum level of antithrombin III
(ATIII) could serve as a prognostic biomarker in neonatal sepsis.
Fetal Pediatr Pathol. 38:290–298. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Lu Z, Cheng D, Yin J, Wu R, Zhang G, Zhao
Q, Wang N, Wang F and Liang M: Antithrombin III protects against
contrast-induced nephropathy. EBioMedicine. 17:101–107.
2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Wang F, Zhang G, Lu Z, Geurts AM, Usa K,
Jacob HJ, Cowley AW, Wang N and Liang M: Antithrombin III/SerpinC1
insufficiency exacerbates renal ischemia/reperfusion injury. Kidney
Int. 88:796–803. 2015. View Article : Google Scholar
|
|
37
|
Lu J, Niu D, Zheng D, Zhang Q and Li W:
Predictive value of combining the level of lipoprotein-associated
phospholipase A2 and antithrombin III for acute coronary syndrome
risk. Biomed Rep. 9:517–522. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lipets EN and Ataullakhanov FI: Global
assays of hemostasis in the diagnostics of hypercoagulation and
evaluation of thrombosis risk. Thromb J. 13(4)2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Brummel-Ziedins K, Undas A, Orfeo T,
Gissel M, Butenas S, Zmudka K and Mann KG: Thrombin generation in
acute coronary syndrome and stable coronary artery disease:
Dependence on plasma factor composition. J Thromb Haemost.
6:104–110. 2008.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hong X, Shan PR, Hu L, Huang ZQ, Wu GJ,
Xiao FY and Huang WJ: Relationship between antithrombin-III value
with acute coronary syndrome and preprocedural TIMI flow grade.
Zhonghua Yi Xue Za Zhi. 92:831–834. 2012.PubMed/NCBI(In Chinese).
|
